← FDA Drug Approvals (Drugs@FDA)

CHOLESTYRAMINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MICRO LABS · Approved 2026-03-05

Drug application

FDA Application #

ANDA219318

Application type

Abbreviated New Drug Application (Generic)

Brand name

CHOLESTYRAMINE

Generic name

CHOLESTYRAMINE

Active ingredients

CHOLESTYRAMINE

Dosage form

POWDER

Route

ORAL

Marketing status

Prescription

Sponsor

MICRO LABS

Manufacturer

Micro Labs Limited

First approval

2026-03-05

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown